Aralez Pharmaceuticals Inc. (ARLZ) Slipped -13.86% or -0.28 To Price $1.74 On Tuesday

Aralez Pharmaceuticals Inc. (ARLZ) slipped -13.86% or -0.28 to $1.74. It is near 2.53 million shares traded, which is 462.3% compare to the average total volume 548106. The market cap of ARLZ is $116.53 million. The year to date change is 27.04%. The 52 week price range is from $0.95 to $3.32. Price of ARLZ have changed 3.06% during last week. It have changed 16.76% over last month, 36.49% over last 3 months, 48.53% over last 6 months and -17.89% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ARLZ is 1.76. It is 1.15% above current price. The 200-day Moving Averages for ARLZ is 1.53. It is -12.07% below current price. The 52-week High is 3.32. It is 90.80% from the current price. The 52-week Low is 0.95. It is -45.40% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ARLZ is 5.91 on 2018-02-28. Short % to float is 4.35%. There are some statistics of ARLZ. It is has market cap $116.53 million. The share outstanding is 66.97 million. The average volume is 548106. The revenue is 97.93M. The gross profit is 86.67M. The percent of top 15 Institution holding is 14.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ARLZ is -101.22%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ARLZ is -28.79%.


Share this post